ABVC BIOPHARMA, INC.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
NV
Business Address
44370 OLD WARM SPRINGS BLVD., FREMONT, CA, 94538
Mailing Address
44370 OLD WARM SPRINGS BLVD., FREMONT, CA, 94538
Phone
510-668-0881
Fiscal Year End
1231
EIN
260014658
Financial Overview
FY2025
$-0.39
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 27, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | March 5, 2026 | View on SEC |
| 8-K Current report of material events | March 3, 2026 | View on SEC |
| 10-Q/A Quarterly report amendment | March 3, 2026 | View on SEC |
| 10-K Annual financial report | March 3, 2026 | View on SEC |
| 8-K/A Current report amendment | January 16, 2026 | View on SEC |
| 424B4 Prospectus for IPO or offering | November 14, 2025 | View on SEC |
| 424B4 Prospectus for IPO or offering | November 14, 2025 | View on SEC |
| 424B4 Prospectus for IPO or offering | November 14, 2025 | View on SEC |
| 424B4 Prospectus for IPO or offering | November 14, 2025 | View on SEC |
Annual Reports
10-K
March 3, 2026
- Advancing multiple drug candidates through early-stage clinical trials, including Phase II completions and initiations.
- Secured a $3.0 million distribution agreement for its maitake supplement, renewed through December 2026, covering China and Taiwan.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.